Starting next month, the Food and Drug Administration will restrict who can make and sell popular weight-loss medications known as GLP-1s.
Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...
Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.
9h
The growing interest in Mounjaro shows an increasing awareness of metabolic health, which is a positive trend. However, ...
A MOTHER has revealed that she has lost 10 and a half stone after using Mounjaro. Becca Banks, a mum-of-one from the UK, ...
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...
A MOTHER has revealed that she lost over eight stone after using fat jabs for two years. Bridget claimed that everyone said ...
US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...
MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
Drugs like Ozempic and Wegovy have the power to block the forces driving obesity, but the knock-on societal effects may not necessarily be so positive ...
GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to ...
Swedish company Sigrid’s weight loss product Carb Fence has been recognised by the US Food and Drug Administration as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback